Dose Escalation Assessment Among Targeted Immunomodulators in the Management of Inflammatory Bowel Disease

BACKGROUND: The need for individualized treatment regimens is becoming more important in the management of patients with inflammatory bowel disease (IBD). Gastroenterologists may dose adjust either by increasing the dose or shortening the dosing interval from the initial recommended maintenance dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehrenberg, Rahel, Griffith, Jenny, Theigs, Cindy, McDonald, Bryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391226/
https://www.ncbi.nlm.nih.gov/pubmed/32191593
http://dx.doi.org/10.18553/jmcp.2020.19388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391226/
https://www.ncbi.nlm.nih.gov/pubmed/32191593
http://dx.doi.org/10.18553/jmcp.2020.19388

Ejemplares similares